US and EU Reject UN Pandemic Preparedness Declaration Over IP and Ideological Disputes
The United States and the European Union have formally rejected a non-binding United Nations declaration designed to coordinate global responses to future pandemics, citing disagreements over intellectual property protections and reproductive health language.
By Ishani Patel
- U.S. and EU Negotiators
- Argue that pandemic preparedness must protect intellectual property rights and avoid mandating ideological or financial commitments.
- Developing Nations and UN Advocates
- Maintain that global solidarity, equity, and shared technology are essential to prevent the resource hoarding seen during COVID-19.
- Public Health Watchdogs
- Warn that failing to reach a consensus on basic collaboration leaves the world vulnerable to future biological threats.
Perspectives this story doesn't cover
- Pharmaceutical Industry Executives
- Global South Health Ministries
Why this matters
Global health agreements rely on the financial and logistical backing of wealthy nations to function during a crisis. Without U.S. and EU participation, international efforts to distribute vaccines and monitor pathogens in developing countries remain structurally underfunded.
The final text of a global agreement is determined not when it is drafted, but when member states decide whether to adopt its commitments on the floor of the United Nations General Assembly. For the newly proposed UN declaration on pandemic preparedness, that decisive step has resulted in a significant diplomatic fracture. The United States and the 27-nation European Union formally rejected the non-binding document on Friday, September 25, 2026, citing irreconcilable differences over intellectual property rights, mandatory technology transfers, and specific ideological language.[1][2]
The declaration was presented to the 193-member body during the second UN General Assembly High-Level Meeting on Pandemic Prevention, Preparedness and Response in New York. Six years after the 2020 COVID-19 crisis forced the assembly to convene virtually, the document was designed to establish a coordinated international framework. Its provisions aimed to boost laboratory capacity, enhance disease surveillance, and ensure that essential medical products could be delivered within the first 100 days of a new biological threat.[2][4]
While the text is largely ceremonial and does not legally bind governments to a specific domestic response, its universal endorsement was intended to signal a unified political commitment. Instead, the rejection by some of the world's wealthiest nations highlights a persistent divide between high-income countries and developing nations regarding how medical resources should be shared. During the coronavirus pandemic, low-income nations lagged richer countries by more than 12 months in securing vaccine access for their citizens.[1]
The European Union's objections focused primarily on the economic and structural mechanisms proposed for future crises. EU representatives stated that the document crossed explicit red lines regarding intellectual property protections and proposed financial commitments. The bloc opposed language that could compel pharmaceutical companies to share proprietary formulas or manufacturing processes with international partners.[1][4]
"Technology transfer must be voluntary and on mutually agreed terms," the EU noted in its official statement. An EU spokesperson added that while the bloc supports the overarching objective of strengthening pandemic prevention, it could not agree with elements that "set us back in the achievement of that objective." The EU did acknowledge that the declaration contained useful provisions for early detection and the One Health approach linking human, animal, and environmental health.[1][4]
"Technology transfer must be voluntary and on mutually agreed terms," the EU noted in its official statement.
The United States' opposition stemmed from a different set of concerns. During negotiations, the U.S. administration sought the removal of references to equity, solidarity, sexual and reproductive health services, and gender equality. The draft had endorsed ensuring universal access to family planning and sexual health services by the year 2030, which U.S. negotiators argued fell outside the scope of pathogen containment.[1][2][4]
Dr. Erica Schwartz, director of the U.S. Centers for Disease Control and Prevention, stated that the text included "divisive ideologies that lack definitional consensus." Despite revisions made during the drafting process, U.S. officials maintained that the final language remained unacceptable and refused to endorse the document.[4]
The rejection was not limited to the U.S. and the EU; Italy also explicitly refused to adopt the text. Meanwhile, representatives from India and Germany voiced reservations about certain provisions but stopped short of outright rejection. A Caribbean countries' association and a coalition of African nations, represented by Burundian Foreign Minister Edouard Bizimana, fully backed the document as an expression of international solidarity.[1][2][4]
Public health advocates and former officials expressed concern over the breakdown in consensus. Helen Clark, former prime minister of New Zealand and co-chair of the Independent Panel for Pandemic Preparedness and Response, noted her frustration with the outcome. "Agreeing to collaborate to prevent, prepare for and respond to pandemics should not be controversial," Clark said.[1]
The draft declaration will now be forwarded to the broader General Assembly for future consideration, where it is still expected to garner enough votes from developing nations to be adopted. Implementing a global preparedness strategy without the financial and logistical backing of the U.S. and the EU leaves the international community navigating the same structural divides that characterized the last global health emergency.[1][4]
Viewpoints in depth
The Intellectual Property Defense
High-income regions argue that mandatory technology transfers undermine the pharmaceutical innovation required to develop vaccines.
For the European Union and aligned nations, the red line in global health agreements remains intellectual property. Negotiators argue that the rapid development of mRNA vaccines during the COVID-19 pandemic was driven by private investment and proprietary research. Mandating the transfer of these technologies to developing nations, they contend, would disincentivize companies from investing in future countermeasures. The EU insists that any sharing of medical technology must remain strictly voluntary and commercially negotiated.
The Demand for Global Equity
Developing nations and health advocates argue that a pandemic response cannot rely on the charity of wealthy countries.
Proponents of the UN declaration point to the stark inequalities of the coronavirus pandemic, where low-income nations waited more than a year for vaccine access while wealthy countries secured surplus doses. For these nations, references to equity and solidarity are not abstract concepts but necessary mechanisms to ensure that life-saving diagnostics and treatments are distributed based on public health needs rather than purchasing power. They argue that a global threat requires a legally and financially binding commitment to resource sharing.
The Ideological Divide
U.S. objections center on the inclusion of social and reproductive health language in a disease preparedness document.
The U.S. administration's rejection highlights a growing friction over how broad the scope of public health should be. U.S. officials, including CDC leadership, objected to the inclusion of terms related to sexual and reproductive health services and gender equality, arguing these represent divisive ideologies that distract from the core mission of pathogen surveillance and containment. This perspective insists that international health treaties should be strictly confined to epidemiological and logistical frameworks.
Key points
- The U.S. and the 27-nation EU rejected a UN declaration aimed at coordinating international pandemic responses.
- EU negotiators objected to language that could mandate the transfer of proprietary pharmaceutical technology.
- U.S. officials cited ideological disagreements over the inclusion of reproductive health and gender equality provisions.
- The non-binding document will still advance to the broader General Assembly, where it is expected to pass with support from developing nations.
Sources
[1]The New York TimesU.S. and EU NegotiatorsU.S. Rejects U.N. Declaration On Preparing For Future Pandemics
Read on The New York Times →
[2]AP NewsDeveloping Nations and UN AdvocatesUN tries to build momentum on pandemic preparedness, but hits a speed bump
Read on AP News →
[3]Jerusalem PostDeveloping Nations and UN AdvocatesUS, EU reject UN declaration promising international collaboration in face of another pandemic
Read on Jerusalem Post →
[4]The Hans IndiaU.S. and EU NegotiatorsUS, EU reject UN pandemic plan
Read on The Hans India →
[5]Opinión Pública TVPublic Health WatchdogsU.S. rejects U.N. declaration on preparing for future pandemics
Read on Opinión Pública TV →
Comments
More in Science
See all →Climate Thresholds
The Nine Climate Tipping Elements and the Temperature Thresholds That Trigger Irreversible Change
8 sources
Forest Ecology
The Staggered Gradient: How Far Forest Edge Effects Penetrate to Alter Microclimates and Species
7 sources
Molecular Geometry
How Valence Electron Pair Repulsion Dictates the Three-Dimensional Shape of Molecules
5 sources
Astrobiology
Earth Microbes Survive Enceladus Ocean Conditions as Plumes Show Path to Detecting Alien Life
5 sources
Every angle. Every day.
Get Science stories with full source coverage and perspective breakdowns delivered to your inbox.




